Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
If a budget falls apart, identify the breach, stop further spirals, and implement a simple recovery plan to restore stability.
16,771 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Investors are using margin loans to amplify gains, but rising leverage could trigger sharp moves. The latest margin d...
Standard Chartered challenges the de-dollarization narrative, arguing that global focus remains on the U.S. dollar as...
Markets remain volatile in 2026, pushing investors toward durable, dividend-rich names. This report lays out the best...
Apollo-owned Michaels is reshaping its business by absorbing assets from rival bankruptcies, expanding party and fabr...
A retirement wave, not automation, is tightening the U.S. labor pool. This piece explains how aging workers impact So...
Archer Aviation sparked a strong intraday move after revealing Thunder, a hybrid VTOL platform developed with Anduril...